RNF32

gene
On this page

Also known as FKSG33HSD15LMBR2

Summary

RNF32 (ring finger protein 32, HGNC:17118) is a protein-coding gene on chromosome 7q36.3, encoding RING finger protein 32 (Q9H0A6). May play a role in sperm formation.

The protein encoded by this gene contains two RING ring finger motifs. RING finger motifs are present in a variety of functionally distinct proteins and are known to be involved in protein-DNA or protein-protein interactions. This gene was found to be expressed during spermatogenesis, most likely in spermatocytes and/or in spermatids. Alternative splicing of this gene results in multiple transcript variants.

Source: NCBI Gene 140545 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 22 total
  • Dosage sensitivity (ClinGen): haploinsufficiency dosage sensitivity unlikely, triplosensitivity no evidence
  • MANE Select transcript: NM_030936

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:17118
Approved symbolRNF32
Namering finger protein 32
Location7q36.3
Locus typegene with protein product
StatusApproved
AliasesFKSG33, HSD15, LMBR2
Ensembl geneENSG00000105982
Ensembl biotypeprotein_coding
OMIM610241
Entrez140545

Gene structure

Transcript identifiers

Ensembl transcripts: 24 — 18 protein_coding, 4 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay, 1 retained_intron

ENST00000311822, ENST00000317955, ENST00000392741, ENST00000392743, ENST00000392747, ENST00000404282, ENST00000405335, ENST00000432459, ENST00000439609, ENST00000463028, ENST00000469382, ENST00000472537, ENST00000480011, ENST00000493999, ENST00000886327, ENST00000886328, ENST00000886329, ENST00000886330, ENST00000886331, ENST00000886332, ENST00000886333, ENST00000886334, ENST00000972044, ENST00000972045

RefSeq mRNA: 5 — MANE Select: NM_030936 NM_001184996, NM_001184997, NM_001308273, NM_001308274, NM_030936

CCDS: CCDS5944, CCDS78292, CCDS78293

Canonical transcript exons

ENST00000317955 — 9 exons

ExonStartEnd
ENSE00001346774156640774156640811
ENSE00003461428156658462156658570
ENSE00003477849156658128156658252
ENSE00003485634156643801156643892
ENSE00003493996156644499156644757
ENSE00003524487156654576156654718
ENSE00003535407156657541156657573
ENSE00003555739156676419156677130
ENSE00003634462156675696156675863

Expression profiles

Bgee: expression breadth ubiquitous, 184 present calls, max score 95.84.

FANTOM5 (CAGE): breadth broad, TPM avg 1.6648 / max 136.2277, expressed in 788 samples.

FANTOM5 promoters (5 alternative TSS)

Promoter IDTPM avgSamples expressed
822670.7696407
822660.4993218
822650.233097
822680.158162
822690.00483

Top tissues by expression

279 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
left testisUBERON:000453395.84gold quality
right testisUBERON:000453495.31gold quality
spermCL:000001994.37gold quality
testisUBERON:000047392.89gold quality
male germ cellCL:000001592.13gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047389.72gold quality
adult organismUBERON:000702378.48gold quality
bronchial epithelial cellCL:000232878.27gold quality
C1 segment of cervical spinal cordUBERON:000646975.21gold quality
right uterine tubeUBERON:000130274.85gold quality
epithelium of bronchusUBERON:000203173.26gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099173.11gold quality
spinal cordUBERON:000224072.37gold quality
bronchusUBERON:000218572.09gold quality
islet of LangerhansUBERON:000000672.03gold quality
cortical plateUBERON:000534372.02gold quality
left adrenal gland cortexUBERON:003582571.15gold quality
body of stomachUBERON:000116170.95gold quality
right lungUBERON:000216770.66gold quality
left adrenal glandUBERON:000123470.38gold quality
body of pancreasUBERON:000115070.35gold quality
right adrenal glandUBERON:000123369.92gold quality
adrenal tissueUBERON:001830369.82gold quality
olfactory segment of nasal mucosaUBERON:000538669.72gold quality
prefrontal cortexUBERON:000045169.71gold quality
metanephros cortexUBERON:001053369.66gold quality
pancreasUBERON:000126469.57gold quality
right adrenal gland cortexUBERON:003582769.51gold quality
anterior cingulate cortexUBERON:000983569.45gold quality
amygdalaUBERON:000187669.42gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-MTAB-6386no75.38
E-ENAD-17no41.87
E-ANND-3no3.34

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

27 targeting RNF32, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-9983-3P99.9471.483631
HSA-MIR-129-5P99.8870.263273
HSA-MIR-394199.8670.542735
HSA-MIR-556-3P99.7468.751203
HSA-MIR-46699.6770.852863
HSA-MIR-130399.6569.771662
HSA-MIR-368599.6268.831621
HSA-MIR-3616-5P99.5567.02989
HSA-MIR-57399.5567.44955
HSA-MIR-3120-3P99.5470.282669
HSA-MIR-467299.5071.582893
HSA-MIR-21-5P99.4670.541035
HSA-MIR-1912-3P99.3267.40936
HSA-MIR-4477B99.2370.491733
HSA-MIR-10399-5P99.1769.872610
HSA-MIR-6504-3P99.1769.312891
HSA-MIR-429299.1665.571767
HSA-MIR-6791-5P99.1665.921844
HSA-MIR-670-3P99.0368.882404
HSA-MIR-155-3P99.0367.99924
HSA-MIR-1295B-5P99.0367.50810
HSA-MIR-181A-2-3P98.9167.601168
HSA-MIR-127997.8367.501898
HSA-MIR-4786-5P97.4567.89924
HSA-MIR-122-5P97.2364.921024
HSA-MIR-4433B-3P97.2263.62663
HSA-MIR-6802-5P94.9465.95366

Functional genomics

ClinGen dosage: haploinsufficiency 40 (dosage sensitivity unlikely), triplosensitivity 0 (no evidence). ClinGen Gene Dosage Map

Literature-anchored findings (GeneRIF, showing 1)

  • molecular cloning of a RING domain protein expressed during sperm formation (PMID:11890671)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriornf32ENSDARG00000060035
mus_musculusRnf32ENSMUSG00000029130
rattus_norvegicusRnf32ENSRNOG00000005691

Protein

Protein identifiers

RING finger protein 32Q9H0A6 (reviewed: Q9H0A6)

All UniProt accessions (4): Q9H0A6, C9JXI4, E9PES2, G5E940

UniProt curated annotations — full annotation on UniProt →

Function. May play a role in sperm formation.

Subcellular location. Cytoplasm.

Tissue specificity. Highly expressed in testis, less abundant in ovary.

Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.

Isoforms (5)

UniProt IDNamesCanonical?
Q9H0A6-11yes
Q9H0A6-22
Q9H0A6-43
Q9H0A6-54
Q9H0A6-65

RefSeq proteins (5): NP_001171925, NP_001171926, NP_001295202, NP_001295203, NP_112198* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000048IQ_motif_EF-hand-BSBinding_site
IPR001841Znf_RINGDomain
IPR013083Znf_RING/FYVE/PHDHomologous_superfamily
IPR027370Znf-RING_eukDomain
IPR042862RNF32Family

Pfam: PF00612, PF13445, PF13639

UniProt features (14 total): splice variant 6, sequence variant 3, zinc finger region 2, chain 1, domain 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9H0A6-F179.810.47

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 91 (showing top): TGCGCANK_UNKNOWN, GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP, SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP, SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP, FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN, GOCC_AGGRESOME, NUYTTEN_EZH2_TARGETS_DN, GOCC_INCLUSION_BODY, GAVIN_FOXP3_TARGETS_CLUSTER_P7, ZHAN_MULTIPLE_MYELOMA_MS_UP, PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, CREB3L4_TARGET_GENES, FOXD2_TARGET_GENES, GLI3_TARGET_GENES

GO Biological Process (0):

GO Molecular Function (3): zinc ion binding (GO:0008270), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (5): endosome (GO:0005768), cytosol (GO:0005829), aggresome (GO:0016235), nuclear body (GO:0016604), cytoplasm (GO:0005737)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure2
transition metal ion binding1
binding1
cation binding1
endomembrane system1
cytoplasmic vesicle1
cytoplasm1
inclusion body1
nucleoplasm1
intracellular membraneless organelle1
intracellular anatomical structure1

Protein interactions and networks

STRING

490 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
RNF32LMBR1Q8WVP7796
RNF32NOM1Q5C9Z4775
RNF32RBM33Q96EV2655
RNF32UBE3CQ15386551
RNF32LZTS3O60299520
RNF32MNX1P50219518
RNF32ACSM1Q08AH1517
RNF32DLDP09622492
RNF32ABT1Q9ULW3469
RNF32SHHQ15465453
RNF32BLTP2Q14667406
RNF32LRRC72A6NJI9405
RNF32DNAJB6O75190384
RNF32CSTL1Q9H114373
RNF32ZP2Q05996373

IntAct

38 interactions, top by confidence:

ABTypeScore
RNF32FBXL12psi-mi:“MI:0407”(direct interaction)0.530
PRAM1RNF32psi-mi:“MI:0407”(direct interaction)0.530
RNF32STAMBPL1psi-mi:“MI:0407”(direct interaction)0.530
RNF32FBXL12psi-mi:“MI:0915”(physical association)0.530
PRAM1RNF32psi-mi:“MI:0915”(physical association)0.530
RNF32STAMBPL1psi-mi:“MI:0915”(physical association)0.530
RNF32HNRNPDLpsi-mi:“MI:0915”(physical association)0.400
RNF32H1-4psi-mi:“MI:0915”(physical association)0.400
RNF32IGLC2psi-mi:“MI:0915”(physical association)0.400
RNF32HIP2psi-mi:“MI:0915”(physical association)0.370
RNF32A2Mpsi-mi:“MI:0915”(physical association)0.370
RNF32CDC37psi-mi:“MI:0915”(physical association)0.370
NOS3RNF32psi-mi:“MI:0915”(physical association)0.370
RNF32PSEN2psi-mi:“MI:0915”(physical association)0.370
APPRNF32psi-mi:“MI:0915”(physical association)0.370
APOERNF32psi-mi:“MI:0915”(physical association)0.370
BLMHRNF32psi-mi:“MI:0915”(physical association)0.370
CDK5RNF32psi-mi:“MI:0915”(physical association)0.370
ECSITRNF32psi-mi:“MI:0915”(physical association)0.370
ELAVL3RNF32psi-mi:“MI:0915”(physical association)0.370
EXOSC1RNF32psi-mi:“MI:0915”(physical association)0.370
RNF32GCDHpsi-mi:“MI:0915”(physical association)0.370
RNF32IFIT5psi-mi:“MI:0915”(physical association)0.370
LONP1RNF32psi-mi:“MI:0915”(physical association)0.370
RNF32OGApsi-mi:“MI:0915”(physical association)0.370
RNF32PRDX2psi-mi:“MI:0915”(physical association)0.370
RNF32RAD23Apsi-mi:“MI:0915”(physical association)0.370
LZTS2RNF32psi-mi:“MI:0915”(physical association)0.370
FBXW4RNF32psi-mi:“MI:0915”(physical association)0.370
RNF32CYP2C9psi-mi:“MI:0915”(physical association)0.370

BioGRID (52): RNF32 (Reconstituted Complex), RNF32 (Proximity Label-MS), RNF32 (Proximity Label-MS), RNF32 (Affinity Capture-MS), IGLC2 (Affinity Capture-MS), RNF32 (Reconstituted Complex), RNF32 (Two-hybrid), APP (Reconstituted Complex), RNF32 (Two-hybrid), RNF32 (Two-hybrid), RNF32 (Two-hybrid), RNF32 (Two-hybrid), APP (Two-hybrid), APOE (Two-hybrid), BLMH (Two-hybrid)

ESM2 similar proteins: A6QQJ8, A9JTG5, B0F0H3, D3YY23, E0X9N4, E6ZIJ1, E9QAM5, O14976, P39428, P97874, Q13064, Q13077, Q17RB8, Q1L5Z9, Q1L8G6, Q1LXR6, Q2TA39, Q4R5T4, Q5FWT8, Q5NU13, Q5R7G8, Q5REG4, Q5T124, Q5ZA07, Q60764, Q6AXL8, Q6GLD9, Q6IDS6, Q6NZR5, Q76LS9, Q80V91, Q8IZP6, Q8K1S6, Q8N5J2, Q8N9I9, Q8R512, Q8WWL2, Q99KY4, Q9CQR5, Q9D572

Diamond homologs: Q4R5T4, Q94AK4, Q9H0A6, Q9JIT1, Q9FGI1

SIGNOR signaling

1 interactions.

AEffectBMechanism
Ub:E2“up-regulates activity”RNF32ubiquitination

Disease & clinical

Clinical variants and AI predictions

ClinVar

22 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance18
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

2087 predictions. Top by Δscore:

VariantEffectΔscore
7:156644758:GT:Gdonor_loss1.0000
7:156644759:T:TCdonor_loss1.0000
7:156657652:GCTCC:Gdonor_gain1.0000
7:156675861:CAGG:Cdonor_loss1.0000
7:156675864:GT:Gdonor_loss1.0000
7:156675865:T:Adonor_loss1.0000
7:156640830:G:Tdonor_gain0.9900
7:156640835:G:Tdonor_gain0.9900
7:156640840:A:Tdonor_gain0.9900
7:156644497:AG:Aacceptor_gain0.9900
7:156644498:GG:Gacceptor_gain0.9900
7:156644756:GG:Gdonor_gain0.9900
7:156644757:GG:Gdonor_gain0.9900
7:156644758:G:GGdonor_gain0.9900
7:156654734:GG:Gdonor_gain0.9900
7:156654735:GG:Gdonor_gain0.9900
7:156655148:G:GGdonor_gain0.9900
7:156675694:A:AGacceptor_gain0.9900
7:156675695:G:GGacceptor_gain0.9900
7:156640818:A:Tdonor_gain0.9800
7:156640943:GCT:Gdonor_gain0.9800
7:156654695:G:GTdonor_gain0.9800
7:156655059:T:Gdonor_gain0.9800
7:156658544:T:Gdonor_gain0.9800
7:156675692:TCA:Tacceptor_loss0.9800
7:156675695:G:GAacceptor_loss0.9800
7:156640830:G:GTdonor_gain0.9700
7:156644493:TTTTA:Tacceptor_loss0.9700
7:156644494:TTTAG:Tacceptor_loss0.9700
7:156644495:TTA:Tacceptor_loss0.9700

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000084089 (7:156655188 T>C), RS1000198825 (7:156667919 C>T), RS1000282111 (7:156667347 T>C), RS1000291425 (7:156667613 A>G), RS1000311672 (7:156639803 G>A), RS1000326058 (7:156661763 G>A), RS1000351832 (7:156655428 T>C), RS1000461957 (7:156661468 C>T), RS1000476901 (7:156672461 A>G), RS1000532362 (7:156676826 A>G), RS1000575566 (7:156672249 G>A), RS1000620344 (7:156665967 A>G), RS1000804997 (7:156660352 C>G,T), RS1000846412 (7:156638850 T>C), RS1000888263 (7:156676905 G>A,C)

Disease associations

OMIM: gene MIM:610241 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST003372_34Glomerular filtration rate (creatinine)1.000000e-09

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

26 total (human), top 26 by PubMed support.

ChemicalActions (top 5)PubMed papers
methylmercuric chloridedecreases expression1
bisphenol Adecreases expression1
trichostatin Adecreases expression1
tris(2-butoxyethyl) phosphateaffects expression1
sodium arseniteaffects acetylation, affects methylation1
butyraldehydedecreases expression1
pentanaldecreases expression1
di-n-butylphosphoric acidaffects expression1
CGP 52608affects binding, increases reaction1
monomethylarsonous acidaffects methylation, affects acetylation1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, increases expression1
dorsomorphinaffects cotreatment, increases expression1
jinfukangincreases expression1
Leflunomidedecreases expression1
Air Pollutantsincreases abundance, increases expression1
Benzo(a)pyrenedecreases expression1
Estradiolaffects cotreatment, increases expression1
Folic Aciddecreases expression1
Formaldehydeincreases expression1
Hydrogen Peroxidedecreases expression1
Mercuric Chlorideincreases expression, affects cotreatment1
Smokeincreases abundance, increases expression1
Tetrachlorodibenzodioxinaffects cotreatment, increases expression1
Tobacco Smoke Pollutiondecreases expression1
Okadaic Aciddecreases expression1
Acrylamideincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.